Thermal and non-thermal plasma technology shows potential for treating chronic non-healing wounds. Plasma generates thermal energy for coagulation and vaporization as well as kinetic energy for cutting and fluid dispersal in a precise and controllable manner. It allows for direct sterilization of wounds and stimulation of cell proliferation and wound healing through effects like increased nitric oxide production. Initial clinical evidence indicates plasma treatment may accelerate bacterial inactivation and promote faster wound healing with minimal side effects due to limited thermal spread.
Lack of association between CD45 C77G polymorphism and multiple sclerosis in ...ijtsrd
Multiple sclerosis (MS) is a severe disabling and demyelinating disease of the nervous system. Its etiology involves profound genetic component. The latest contender known to have been correlated with MS is protein tyrosine phosphatase receptor-type C (PTPRC or CD45); however, to date its role remains contentious. The aim of the current study was to examine the association of functionally significant exon 4 C77G polymorphism of CD45 with MS in Kashmiri population from Indian subcontinent. The preliminary findings of our study revealed absence of C77G in majority of the cases as well as controls. These findings strongly suggest that the alterations in CD45 are sporadically associated with the genesis of MS. In conclusion, results from our study are in accordance with some of the international studies; however, more studies with large datasets from Kashmir as well as other ethnic populations are warranted to validate the above preliminary findings and demonstrate the role of CD45 C77G polymorphism in MS pathogenesis. Insha Zahoor | Amrina Shafi | Mudasir A Mir"Lack of association between CD45 C77G polymorphism and multiple sclerosis in Kashmir" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-1 | Issue-6 , October 2017, URL: http://www.ijtsrd.com/papers/ijtsrd5813.pdf http://www.ijtsrd.com/biological-science/biotechnology/5813/lack-of-association-between-cd45-c77g-polymorphism-and--multiple-sclerosis-in-kashmir/insha-zahoor
Benjamin Korman, MD discusses the genetics of scleroderma and the genomic era. Genetics and genomics are complicated, and getting more so every day. Every patient is genetically unique, but new technology will make it easier to understand individuals’ genetic susceptibility to disease and response to therapy.
Lack of association between CD45 C77G polymorphism and multiple sclerosis in ...ijtsrd
Multiple sclerosis (MS) is a severe disabling and demyelinating disease of the nervous system. Its etiology involves profound genetic component. The latest contender known to have been correlated with MS is protein tyrosine phosphatase receptor-type C (PTPRC or CD45); however, to date its role remains contentious. The aim of the current study was to examine the association of functionally significant exon 4 C77G polymorphism of CD45 with MS in Kashmiri population from Indian subcontinent. The preliminary findings of our study revealed absence of C77G in majority of the cases as well as controls. These findings strongly suggest that the alterations in CD45 are sporadically associated with the genesis of MS. In conclusion, results from our study are in accordance with some of the international studies; however, more studies with large datasets from Kashmir as well as other ethnic populations are warranted to validate the above preliminary findings and demonstrate the role of CD45 C77G polymorphism in MS pathogenesis. Insha Zahoor | Amrina Shafi | Mudasir A Mir"Lack of association between CD45 C77G polymorphism and multiple sclerosis in Kashmir" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-1 | Issue-6 , October 2017, URL: http://www.ijtsrd.com/papers/ijtsrd5813.pdf http://www.ijtsrd.com/biological-science/biotechnology/5813/lack-of-association-between-cd45-c77g-polymorphism-and--multiple-sclerosis-in-kashmir/insha-zahoor
Benjamin Korman, MD discusses the genetics of scleroderma and the genomic era. Genetics and genomics are complicated, and getting more so every day. Every patient is genetically unique, but new technology will make it easier to understand individuals’ genetic susceptibility to disease and response to therapy.
The utility of assessing gene expression in skin to evaluate treatment response: What becomes of all those skin biopsies? is presented by
Monique Hinchcliff MD, MS
Northwestern Scleroderma Program
Presenation Overview:
IgG in PIDD: treatment goals
IgG trough levels and personalizing dose
IGIV vs IGSC: pros and cons today
Enzyme-facilitated IgG administration
Presentation by:
Richard L. Wasserman, MD, PhD
DallasAllergyImmunology Research
Clinical Professor of Pediatrics
University of Texas Southwestern Medical School
Medical Director of Pediatric Allergy and Immunology
Medical City Children’s Hospital
Dallas, Texas
The utility of assessing gene expression in skin to evaluate treatment response: What becomes of all those skin biopsies? is presented by
Monique Hinchcliff MD, MS
Northwestern Scleroderma Program
Presenation Overview:
IgG in PIDD: treatment goals
IgG trough levels and personalizing dose
IGIV vs IGSC: pros and cons today
Enzyme-facilitated IgG administration
Presentation by:
Richard L. Wasserman, MD, PhD
DallasAllergyImmunology Research
Clinical Professor of Pediatrics
University of Texas Southwestern Medical School
Medical Director of Pediatric Allergy and Immunology
Medical City Children’s Hospital
Dallas, Texas
Learn how hyperthermia treatments (thermal therapy) can dramatically improve your response to radiation or chemotherapy. There are several mechanisms for action with how this treatment works biologically, and some cancers respond better than others. Contact Cyrus Rafie at (888) 580-5900 or visit http://www.bhthermalmedicine.com
Audio and slides for this presentation are available on YouTube: http://youtu.be/6W_xoH4s-Yk
Dr. Patrick Wen, of Dana-Farber Cancer Institute's Center for Neuro-Oncology, discusses current clinical trial options for brain tumor patients and some of the new therapies available in neuro-oncology. This presentation was originally given at Dana-Farber Cancer Institute on Dec. 4, 2013.
Antitumor applications of nano-traditional Chinese medicineLucyPi1
An article by Deng et al. [1] that was first published in ACS Nano in 2019 revealed that nanoparticles extracted from cuttlefish ink (CINPs) could inhibit tumor growth by synergizing immunotherapy and photothermal therapy. The researchers found that these CINPs, which had significant antitumor efficacy, could effectively reprogram tumor-associated macrophages (TAMs) from the immune-suppressive M2-like phenotype to the antitumor M1-like phenotype.
What is exposome?
The exposome can be defined as the measure of all the exposures of an individual in a lifetime and how those exposures relate to health.
The aging of the skin may be influenced by various internal or external factors.
Here, we explore the role of various exposures in skin aging.
The 2016 World Health Organization classification of tumors of the central nervous system broadly employs genetic alterations for diagnostic criteria including isocitrate dehydrogenase-1 (IDH1) mutation or IDH2 mutation, and 1p/19q codeletion,[1] with the goal of creating more homogeneous disease categories with greater prognostic value.[2-5] Molecular diagnostics is becoming an increasingly important aspect of clinical oncologic neuropathology practice.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
1. Christian FABRICIUS, M.D., Ph.D
GTC Life Science
Gamlestadsvägen 2-4
S-415 02 Göteborg, Sweden
Irem TEZER, M.D.
Hiperox Wound and Hyperbaric Center
Demirci Kara Mah. Avni Tolunay Cad. No: 46/1
07100 Antalya, Turkey
CHRONIC NON-HEALING WOUND
MANAGEMENT WITH PLASMA TECHNOLOGY
2. • High temperature, low density
argon plasma
• Thermal energy – for coagulation
& vaporization
• Kinetic energy – for cutting &
fluid dispersal
• Controllable, visible effect
• Proprietary technology for rapid
generation of high energy Argon
Plasma
• High temperature
• Low thermal density
CHRONIC NON-HEALING WOUND MANAGEMENT WITH
PLASMA TECHNOLOGY
Thermal and non-thermal plasma
Introduction
• Chronic wounds demand an aggressive,
multifactorial approach. Repetitive surgical
debridement, revascularization, when necessary,
antibiotics and dressings form the foundation of
therapy. However, once the wound is clean and
well vascularized, they still may not progress to
healing. Several adjuvant treatment methods
have been developed to further stimulate healing
and non-thermal plasma seems to be one of
them.
Thermal and Non-thermal plasma
• Plasmas have been used for a long time for
sterilization of medical equipment, packaging in
the food industry, implants, blood coagulation,
etc. This is partly due to their high bactericidal
effectiveness and partly due to their easy access
into narrow and confined spaces. Thermal and
non-thermal (i.e. cold) plasmas – both already
widely established in medicine – are used for
various therapeutic applications. Particularly in
dermatology, plasma applications hold big
potential, for example, in wound healing, such as
efficient disinfection or sterilization, therapy of
various skin infections or tissue regeneration. It
has recently been demonstrated that non-
thermal atmospheric pressure plasma (less than
40 ◦C at the point of application) can be applied
directly to living cells and tissues, killing bacteria
and inducing blood coagulation without
significant heating. Non-thermal plasma
treatment has also been shown to promote cell
proliferation, enhance cell transfection, sterilize
root canals and possibly increase wound healing.
The simplicity and flexibility of devices required
to generate non-thermal plasma and apply it to
tissues is particularly appealing. However, an
understanding of mechanisms by which non-
thermal plasma interacts with living cells and
tissues is required to fully develop its clinical
applications.
Medical plasma for wound healing
• It is reported that direct plasma in contact with
tissue leads to a significantly faster bacteria
inactivation on this tissue due to the presence of
charges. Direct plasma treatment are able to
sterilize and also responsible for many interesting
biological effects; e.g. effect of NO in tissue
regeneration. Optimal NO activity is required for
the full expression and receptor upregulation of
VEGF and PDGF. A deficiency in NO bioactivity is
associated with diabetes-impaired wound healing
. Experimentally and clinically it is validated that
plasmadynamic therapy increases nitric oxide on
wounds and sterilizing the bacteria that helps
wound healing.
3. CHRONIC NON-HEALING WOUND MANAGEMENT WITH
PLASMA TECHNOLOGY
Continuous and distance effects
Vaporization
Energy is focused more than with
coagulation
• Smaller area = higher energy
density
• Vaporization of Rapid Dry Layer
• Progression of thermal diffusion
Cutting with Coagulation
• Energy is tightly focused
• Rapid vaporization takes place
over small area
• Lateral Coagulation occurs with
latent thermal diffusion
The argon plasma is short-lived, and gives up
its energy readily in three useful forms:
• As UV light – in the visible and near ultraviolet
parts of the spectrum, which helpfully illuminates
the field, but is not sufficiently intense to cause
damage or require any eye-protection, antibacterial
wave lenght
• As thermal energy – sufficient to heat the tissue to
a very limited depth and cause coagulation of the
surface bleeding
• In the form of kinetic energy – that clears any
biofilm layer of the bacterias from the surface of the
tissue
5. Literature Cited
Plasma medicine: an introductory review. M G Kong, G Kroesen, G Morfill, T Nosenko, T Shimizu, van Dijk and J
L Zimmermann
Kalghatgi S, Kelly CM, Cerchar E, Torabi B, Alekseev O, et al. (2011) Effects of Non-Thermal Plasma on
Mammalian Cells. PLoS ONE 6(1): e16270. doi:10.1371/journal.pone.0016270
Plasma applications in medicine with a special focus on dermatology. J Heinlin1,†, G Isbary2,†, W Stolz2, G
Morfill3, M Landthaler1, T Shimizu3, B Steffes3, T Nosenko3, JL Zimmermann3 andS Karrer1,* Journal of the
European Academy of Dermatology and Venereology Volume 25, Issue 1, pages 1–11, January 2011
Physical and biological mechanisms of direct plasma interaction with living tissue. Danil Dobrynin et al 2009 New
J. Phys. 11 115020
Fridman G, Shekhter A B, Vasilets V N, Friedman G, Gutsol A and Fridman A 2008 Applied plasma medicine
Plasma Process. Polym. 5 503–33
S and Hynes W L 2006 Inactivation of bacteria by the plasma pencil Plasma Process. Polym. 3 470–3
Fridman G, Brooks A D, Balasubramanian M, Fridman A, Gutsol A, Vasilets V N, Ayan H and Friedman G 2007
Comparison of direct and indirect effects of non-thermal atmospheric pressure plasma on bacteria Plasma
Process. Polym. 4 370–5
Shekhter A B, Serezhenkov V A, Rudenko T G, Pekshev A V and Vanin A F 2005 Beneficial effect of gaseousnitric
oxide on the healing of skin wounds Nitric Oxide-Biol. Chem. 12 210–9
Fukumura D, Gohongi R, Kadambi A, et al. Predominant role of endothelial nitric oxide synthase in vascular
endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci USA.
2001;27(98):2604–9
Dhaunsi GS, Ozand PT. Nitric oxide promotes mitogen-induced DNA synthesis in human dermal fibroblasts
through cGMP. Clin Exp Pharmacol Physiol. 2004;31(12):46–9.
Schaffer MR, Tantry U, Efron PA, Ahrendt GM, Thornton FJ, Barbul A. Diabetes-impaired healing and reduced
nitric oxide synthesis: a possible pathophysiologic correlation. Surgery. 1997;121:513–9
Shekhter A B, Kabisov R K, Pekshev A V, Kozlov N P and Perov Y L 1998 Experimental and clinical validation of
plasmadynamic therapy of wounds with nitric oxide Bull. Exp. Biol. Med. 126 829–34
Sonoda Y, Olvera N, Chi DS, Brown CL, Abu-Rustum NR, Levine DA. Pathologic analysis of ex vivo plasma energy
tumor destruction in patients with ovarian or peritoneal cancer. Int J Gynecol Cancer. 2010; 20:1326-30
Roman H, Pura I, Tarta O, Mokdad C, Auber M, Bourdel N, Marpeau L, Sabourin JC. Vaporization of ovarian
endometrioma using plasma energy: histologic findings of a pilot study. Fertil Steril. 2011; 95:1853-6
Auber M, Bourdel N, Mokdad C, Martin C, Diguet A, Marpeau L, Roman H. Ultrasound ovarian assessments after
endometrioma ablation using plasma energy. Fertil Steril. 2011 ; 95:2621-4
Madhuri TK, Papatheodorou D, Tailor A, Sutton C, Butler-Manuel S. First clinical experience of argon neutral
plasma energy in gynaecological surgery in the UK, Gynecol Surg. 2010; 7:423-425
Deb S, Sahu B, Deen S, Newman C, Powell M. Comparison of tissue effects quantified histologically between
PlasmaJet coagulator and Helica thermal coagulator. Arch Gynecol Obstet. 2012 Aug;286(2):399-40
Nezhat C, Kho KA, Morozov V. Use of neutral argon plasma in the laparoscopic treatment of endometriosis. JSLS.
2009; 13:479-83
Madhuri TK, Tailor A, Butler-Manuel S. Use of neutral plasma coagulation in groin node dissection for vulvar
malignancy: a novel technique. Cancer Manag Res. 2011; 3:253-5
Thermal plasma is a surgically proven new technique for cutting, ablating, coagulating
and drying. In a comparison with traditional wound care it can be used to:
- illuminate the wound area
- coagulate
- clear the wound area from fluids
- create a flexible sealing layer in the wound area
It is thus suitable for infection control as well as debridement. Any side effects of this new
technology is expected to be minimal since the thermal spread is minimized, thus
ensuring delicated precision, still preserving the underlying tissues.
CHRONIC NON-HEALING WOUND MANAGEMENT WITH
PLASMA TECHNOLOGY
Summary